Ruoxi Hong
- Oncology top 10%
- Molecular Biology
- Cancer Research top 10%
- Pulmonary and Respiratory Medicine top 10%
- Radiology, Nuclear Medicine and Imaging
- Topics
- Breast Cancer Treatment Studies (20 papers)HER2/EGFR in Cancer Research (17 papers)Advanced Breast Cancer Therapies (11 papers)
- Partner nations
- ChinaUnited StatesEthiopia
In The Last Decade
Ruoxi Hong
60 papers receiving 873 citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Oncology 418
- Molecular Biology 358
- Cancer Research 265
- Pulmonary and Respiratory Medicine 233
- Radiology, Nuclear Medicine and Imaging 68
Countries citing papers authored by Ruoxi Hong
This map shows the geographic impact of Ruoxi Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruoxi Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruoxi Hong more than expected).
Fields of papers citing papers by Ruoxi Hong
This network shows the impact of papers produced by Ruoxi Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruoxi Hong. The network helps show where Ruoxi Hong may publish in the future.
Co-authorship network of co-authors of Ruoxi Hong
This figure shows the co-authorship network connecting the top 25 collaborators of Ruoxi Hong. A scholar is included among the top collaborators of Ruoxi Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruoxi Hong. Ruoxi Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 0 | |
| 7 | 0 | |
| 8 | 8 | |
| 9 | Breast cancer: an up‐to‐date review and future perspectivesbreakdown → | 206 |
| 10 | 2 | |
| 11 | 23 | |
| 12 | 13 | |
| 13 | 10 | |
| 14 | 15 | |
| 15 | 35 | |
| 16 | 1 | |
| 17 | 10 | |
| 18 | 10 | |
| 19 | 16 | |
| 20 | 30 |
About Ruoxi Hong
Ruoxi Hong is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 67 papers that have together received 884 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (20 papers), HER2/EGFR in Cancer Research (17 papers) and Advanced Breast Cancer Therapies (11 papers). The work is most often cited by research in Cancer Research (265 citations), Oncology (418 citations) and Pulmonary and Respiratory Medicine (233 citations). Ruoxi Hong has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Binghe Xu, Shusen Wang, Qianyi Lu, Fei Xu, Wen Xia, Wenjie Zhu, Qiufan Zheng, Fei Ma, Jinting Li and Kuikui Jiang. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.